APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-4919
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis ; day:2 ; month:1 ; year:2023 ; pages:1-13
Molecular and cellular biochemistry ; (2.1.2023), 1-13
- Creator
-
Ke, Ben
Shen, Wen
Liao, Yunfei
Hu, Jing
Tu, Weiping
Fang, Xiangdong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11010-022-04650-7
- URN
-
urn:nbn:de:101:1-2023031209024222828094
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ke, Ben
- Shen, Wen
- Liao, Yunfei
- Hu, Jing
- Tu, Weiping
- Fang, Xiangdong
- SpringerLink (Online service)
Other Objects (12)
UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation
Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis
Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway
Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway
Apc
Apc
Apc
APC
APC-
Apc
UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation
Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis
Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway
Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway
Apc
Apc
Apc
APC
APC-
Apc
UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation
Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis
Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway
Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway
Apc
Apc
Apc
APC
APC-